Related Experiment Video
Updated: Mar 22, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
LXR activation causes G1/S arrest through inhibiting SKP2 expression in MIN6 pancreatic beta cells
Yating Li1, Changwen Jing1, Xinyi Tang1
1Key Laboratory of Human Functional Genomics of Jiangsu Province, Department of Biochemistry and Molecular Biology, Nanjing Medical University, 140 Hanzhong Road, Nanjing, 210029, People's Republic of China.
Abstract:
Liver X receptors (LXRs) are nuclear hormone receptors with central roles in lipid homeostasis. We previously showed that LXR activation induced aberrant lipid metabolism and G1 cell cycle arrest in pancreatic beta cells. In this study, we aimed to identify the molecular target of LXR causing G1 arrest. LXR activation was induced by its agonist, T0901317. A series of luciferase reporters of truncated Skp2 promoter were analyzed in MIN6 cells. mRNA and protein levels of SKP2 and P27 were detected. Flow cytometry assay was used to determine the cell cycle distribution. MTT assay was used to evaluate cell viability. LXR activation increased cell distribution in G1 phase and lipid accumulation. Since dominant-negative Srebp1c could clear the deposited lipid rather than recover the G1 arrest, we identified S-phase kinase-associated protein 2 (Skp2) as a potential target gene of LXR. In deed, LXR activation significantly inhibited Skp2 gene expression and protein amount. We also observed that the luciferase activity of Skp2 promoter was suppressed by T0901317 and the potential LXR regulatory site was narrowed down to a region of nt -289 to -38. Silencing Lxrα and Lxrβ rescued SKP2 protein level and recovered the cellular growth repressed by LXR activation. Moreover, SKP2 overabundance reduced P27 protein level by promoting its degradation, consequently overcame the G1 arrest caused by T0901317. Our findings demonstrate that transrepressing Skp2 expression by LXR activation resulted in defective SKP2-mediated P27 degradation and inhibitory cell growth in beta cells.
Insights
Liver X receptor (LXR) activation causes pancreatic beta cell G1 arrest by inhibiting S-phase kinase-associated protein 2 (Skp2) expression, disrupting Skp2-mediated P27 degradation and cell growth.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Biology
Background:
- Liver X receptors (LXRs) are key regulators of lipid homeostasis.
- Previous studies indicated LXR activation induces aberrant lipid metabolism and G1 cell cycle arrest in pancreatic beta cells.
Purpose of the Study:
- To identify the specific molecular target of LXR responsible for G1 cell cycle arrest in pancreatic beta cells.
Main Methods:
- Utilized MIN6 cells treated with LXR agonist T0901317.
- Analyzed truncated Skp2 promoter-luciferase reporters.
- Measured SKP2 and P27 mRNA and protein levels.
- Assessed cell cycle distribution via flow cytometry and cell viability using MTT assay.
Main Results:
- LXR activation increased G1 phase distribution and lipid accumulation.
- LXR activation significantly inhibited Skp2 gene and protein expression, with a key regulatory site in the Skp2 promoter identified.
- Silencing LXRα/β rescued Skp2 levels and cell growth.
- SKP2 overexpression overcame LXR-induced G1 arrest by promoting P27 degradation.
Conclusions:
- LXR activation transrepresses Skp2 expression in pancreatic beta cells.
- This inhibition leads to defective Skp2-mediated P27 degradation, causing G1 cell cycle arrest and impaired beta cell growth.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Cell Specific Gene Expression
cAMP-dependent Protein Kinase Pathways
GPCRs Regulate Adenylyl Cylase Activity
Amplifying Signals via Enzymatic Cascade
Negative Regulator Molecules

